Skip to main content
. 2019 Jun 7;6(3):ENEURO.0066-19.2019. doi: 10.1523/ENEURO.0066-19.2019

Table 1.

Statistical analysis of results obtained in behavioral and electrophysiological experiments

Figure Data structure Type of test Sample Size Statistical data
Figure 3A Weight analysis of ctrl and cKO mice Normally distributed Two-way ANOVA followed by Sidak’s multiple comparison test Ctrl N = 14(M = 8, F = 6)cKO N = 23(M = 15, F = 8) Interaction: p = 0.996, F(4,158) = 0.0447Week: p < 0.001, F(4,158) = 79.8Genotype: p = 0.032, F(1,158) = 4.67Multiple comparisonsCtrl vs cKOw4 p = 0.908; 95% CI: –3.55 to 1.75w5 p = 0.966; 95% CI: –2.70 to 1.57w6 p = 0.876; 95% CI: –2.91 to 1.35w7 p = 0.720; 95% CI: –3.19 to 1.15w8 p = 0.783; 95%CI: –3.11 to 1.23
Figure 3B Baseline locomotion of ctrl and cKO mice for 30 min in 5-min bins Normally distributed Two-way RM ANOVA followed by Sidak’s multiple comparison test Ctrl N = 17(M = 8, F = 9)cKO N = 17(M = 13, F = 4) Interaction: p = 0.256, F(5,160) = 1.33Time: p < 0.001, F(5,160) = 69.5Genotype: p = 0.535, F(1,32) = 0.00912Multiple comparisonsCtrl vs cKO5 p > 0.999; 95% CI: –287 to 21110 p > 0.999; 95% CI: –217 to 28215 p = 0.952; 95% CI: –170 to 32920 p > 0.999; 95% CI: –236 to 26325 p = 0.886; 95% CI: –346 to 15330 p = 0.993; 95% CI: –195 to 304
Figure 3C Sucrose preference of ctrl and cKO mice for 1%, 3%, and 10% sucrose solutions Normally distributed Two-way RM ANOVA followed by Sidak’s multiple comparison test Ctrl N = 14(M = 8, F = 6)cKO N = 21(M = 13, F = 8) Interaction: p = 0.475, F(2,66) = 0.752Concentration: p < 0.001, F(2,66) = 151Genotype: p = 0.297, F(1,33) = 1.12Multiple comparisonsCtrl vs cKO1% p > 0.999; 95% CI: –5.21 to 5.693% p = 0.294; 95% CI: –1.83 to 9.0810% p = 0.991; 95% CI: –4.85 to 6.05
Figure 3D Ethanol preference of ctrl and cKO mice for 3%, 6%, and 10% ethanol concentrations Normally distributed Two-way RM ANOVA followed by Sidak’s multiple comparison test Ctrl N = 14(M = 7, F = 7)cKO N = 14(M = 6, F = 8) Interaction: p = 0.129, F(2,52) = 2.13Concentration: p < 0.001, F(2,52) = 14.2Genotype: p = 0.334, F(1,26) = 0.969Multiple comparisonsCtrl vs cKO3% p = 0.983; 95% CI: –9.31 to 7.116% p = 0.453; 95% CI: –3.68 to 12.710% p = 0.396; 95% CI: –3.38 to 13.0Ctrl3% vs 6% p < 0.001; 95% CI: –14.7 to –3.453% vs 10% p < 0.001; 95% CI: –16.9 to –5.586% vs 10% p = 0.733; 95% CI: –7.78 to 3.52cKO3% vs 6% p = 0.354; 95% CI: –9.11 to 2.183% vs 10% p = 0.072; 95% CI: –10.9 to 0.3546% vs 10% p = 0.814; 95% CI: –7.47 to 3.82
Figure 3E Injection-induced locomotion for ctrl and cKO mice after saline and 5, 10, and 20 mg/kg injections of cocaine Normally distributed Two-way RM ANOVA followed by Sidak’s multiple comparison test Ctrl N = 14(M = 8, F = 6)cKO N = 21(M = 13, F = 8) Interaction: p = 0.396, F(3,99) = 1Session: p < 0.001, F(3,99) = 108Genotype: p = 0.208, F(1,33) = 1.65Multiple comparisonsCtrl vs cKOSaline p = 0.966; 95% CI: –3437 to 54365 mg/kg. p = 0.962; 95% CI: –3410 to 546410 mg/kg. p = 0.887; 95% CI: –3015 to 585820 mg/kg. p = 0.152; 95% CI: –802 to 8071
Figure 3F Amphetamine- induced (3 mg/kg) locomotion under a sensitization protocol for ctrl and cKO mice Normally distributed Two-way RM ANOVA followed by Sidak’s multiple comparison test Ctrl N = 17(M = 8, F = 9)cKO N = 17(M = 13, F = 4) Interaction: p < 0.001, F(5,160) = 4.79Session: p < 0.001, F(5,160) = 40.9Genotype: p = 0.005, F(1,32) = 9.09Multiple comparisonsCtrl vs cKODay1 p > 0.999; 95% CI: –13,977 to 12,091Day2 p = 0.266; 95% CI: –3371 to 22,696Day3 p = 0.063; 95% CI: –407 to 25,661Day4 p = 0.011; 95% CI: –2481 to 28,549Day5 p < 0.001; 95% CI: –6873 to 32,941Day17 p = 0.029; 95% CI: –928 to 26,996
Figure 3HCocaine (20 mg/kg, i.p) CPP for ctrl and cKO mice Normally distributed Unpaired t test Ctrl N = 12 (M = 6, F = 6)cKO N = 15 (M = 6, F = 9) t testctrl vs cKOp = 0.860; 95% CI: –162.0 to 136.1
Figure 3H, bottom panelAmphetamine (3 mg/kg, i.p.) CPP for ctrl and cKO mice Assumed normality Unpaired t test Ctrl N = 13 (M = 6, F = 7)cKO N = 16 (M = 9, F = 7) t testctrl vs cKOp = 0.744; 95% CI: –365.5 to 264.3
Figure 3ICocaine-induced locomotion during the CPP for ctrl and cKO mice Assumed normality Two-way RM ANOVA followed by Sidak’s multiple comparison test Ctrl N = 12 (M = 6, F = 6)cKO N = 15 (M = 6, F = 9) Interaction: p = 0.652, F(3,75) = 0.5Session: p = 0.006, F(3,75) = 4.4Genotype: p = 0.031, F(1,25) = 5.2Multiple comparisonsCtrl vs cKOInjection 1: p = 0.373; 95% CI: –6850 to 1526Injection 2: p = 0.067; 95% CI: –8185 to 191Injection 3: p = 0.115; 95% CI: –7818 to 558Injection 4: p = 0.475; 95% CI: –6591 to 1785
Figure 3K, bottom panelAmphetamine-induced locomotion during the CPP for ctrl and cKO mice Normally distributed Mixed-effects model (REML) followed by Sidak’s multiple comparison test Ctrl N = 15 (M = 7, F = 8)cKO N = 17 (M = 10, F = 7) Interaction: p = 0.567, F(3,85) = 0.680Session: p < 0.001, F(3,85) = 24.0Genotype: p = 0.803, F(1,30) = 0.0631Multiple comparisonsCtrl vs cKOInjection 1: p = 0.941; 95% CI: –2522 to 1473Injection 2: p = 0.931; 95% CI: –1431 to 2517Injection 3: p = 0.995; 95% CI: –1783 to 2331Injection 4: p = 0.989; 95% CI: –1671 to 2327
Figure 6D, leftOptically evoked DA release in NAcSh of DAT-, NEX-, and Calb2-Cre mice injected with ChR2 or eYFP Normally distributed Unpaired t test 10 observations for each group and virusDAT-Cre/Chr2 N = 2(M = 0, F = 2)DAT-Cre/eYFP N = 2(M = 1, F = 1)NEX-Cre/Chr2 N = 3(M = 2, F = 1)NEX-Cre/eYFP N = 2(M = 0, F = 2)Calb2-Cre/Chr2 N = 3(M = 1, F = 2)Calb2-Cre/eYFP N = 2(M = 0, F = 2) t testDAT-Cre/ChR2 vs DAT-Cre/eYFPp < 0.0001; 95% CI: –1.272 to –0.6540NEX-Cre/ChR2 vs NEX-Cre/eYFPp < 0.0001; 95% CI: –0.6289 to –0.2909Calb2-Cre/ChR2 vs Calb2-Cre/eYFPp = 0.0148; 95% CI: –0.01602 to –0.001988
Figure 6D, rightOptically evoked DA release in OT of DAT-, NEX-, and Calb2-Cre mice injected with ChR2 or eYFP Normally distributed Unpaired t test As above t testDAT-Cre/ChR2 vs DAT-Cre/eYFPp < 0.0001; 95% CI: –0.2354 to –0.1810NEX-Cre/ChR2 vs NEX-Cre/eYFPp = 0.0049; 95% CI: –0.01295 to –0.002704Calb2-Cre/ChR2 vs Calb2-Cre/eYFPp = 0.0002; 95% CI: –0.02022 to –0.007554
Figure 7D, left panelOptically evoked EPSCs in NAcSh of NEX-Cre/ChR2 mice before (control) and after DNQX bath application Assumed normality Paired t test 6 cells from 3 NEX-Cre/ChR2 mice(M = 3, F = 0) p = 0.0481; 95% CI: –61.86 to –0.3739
Figure 7D, right panelOptically evoked EPSCs in OT of Calb2-Cre/ChR2 mice before (control) and after DNQX bath application Assumed normality Paired t test 5 cells from 3 Calb2-Cre/ChR2 mice(M = 2, F = 1) p = 0.0456; 95% CI: –89.88 to –1.444
Figure 8B, leftBehavioral analysis of DAT-Cre/ChR2 mice throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 10(M = 2, F = 8) Interaction: p < 0.001, F(12,108) = 33Day: p = 0.435, F(6,54) = 1Compartment: p < 0.001, F(2,18) = 51.8Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.513; 95% CI: –38.4 to –6.29Day3 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 21.7 to 66.4Paired vs neutral p < 0.001; 95% CI: 35.7 to 80.4Day4 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 37.6 to 82.3Paired vs neutral p < 0.001; 95% CI: 47.3 to 92.0Day5 (CR)Paired vs unpaired p < 0.001; 95% CI: 11.5 to 56.1Paired vs neutral p < 0.001; 95% CI: 26.7 to 71.4Day6 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –65.7 to –21.0Paired vs neutral p < 0.001; 95% CI: 34.4 to 79.1Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –85.0 to –40.4Paired vs neutral p < 0.001; 95% CI: 43.1 to 87.7Day8 (CR)Paired vs unpaired p < 0.001; 95% CI: –67.2 to –22.5Paired vs neutral p < 0.001; 95% CI: 33.6 to 78.3
Reversal parameters:Day3 paired vs Day6 unpaired p < 0.001; 95% CI: 22.8 to 67.4Day3 paired vs Day7 unpaired p < 0.001; 95% CI: 32.5 to 77.2Day4 paired vs Day6 unpaired p < 0.001; 95% CI: 32.3 to 76.9Day4 paired vs Day7 unpaired p < 0.001; 95% CI: 42.0 to 86.7Day5 paired vs Day8 unpaired p < 0.001; 95% CI: 17.5 to 62.2
Figure 8B, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for DAT-Cre/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 10(M = 2, F = 8) Compartment p < 0.001, F(2,6) = 166Multiple comparisonsPaired vs unpaired p < 0.001; 95% CI: 41.1 to 63.9Paired vs neutral p < 0.001; 95% CI: 51.7 to 74.5Unpaired vs neutral p = 0.066; 95% CI: –0.808 to 22.0
Extended Data Figure 8-1A, leftBehavioral analysis of DAT-Cre-negative mice injected with AAV-ChR2 throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 3(M = 0, F = 3) Interaction: p = 0.562, F(12,24) = 0.898Day: p = 0.569, F(6,12) = 0.830Compartment: p = 0.102, F(2,4) = 4.26Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.010; 95% CI: –49.6 to –4.05Day3 (RT-PP)Paired vs unpaired p = 0.074; 95% CI: 44.5 to 1.05Paired vs neutral p = 0.292; 95% CI: –5.3 to 40.3Day4 (RT-PP)Paired vs unpaired p = 0.236; 95% CI: –41.0 to 4.57Paired vs neutral p = 0.055; 95% CI: –0.241 to 45.3Day5 (CR)Paired vs unpaired p = 0.074; 95% CI: –44.5 to 1.08Paired vs neutral p = 0.204; 95% CI: –4.08 to 41. 5Day6 (RT-PP)Paired vs unpaired p = 0.998; 95% CI: –30.3 to 15.3Paired vs neutral p < 0.001; 95% CI: 12.0 to 57.6Day7 (RT-PP)Paired vs unpaired p = 0.863; 95% CI: –34.5 to 11.0Paired vs neutral p = 0.001; 95% CI: 9.18 to 54.8Day8 (CR)Paired vs unpaired p = 0.012; 95% CI: –49.2 to –3.6Paired vs neutral p < 0.001; 95% CI: 22.5 to 68.1Reversal parameters:Day3 paired vs Day6 unpaired p = 0.995; 95% CI: –30.8 to 14.8Day3 paired vs Day7 unpaired p > 0.999; 95% CI: –27.0 to 18.5Day4 paired vs Day6 unpaired p > 0.999; 95% CI: –28.0 to 17.6Day4 paired vs Day7 unpaired p > 0.999; 95% CI: –24.2 to 21.4Day5 paired vs Day8 unpaired p > 0.999; 95% CI: –21.3 to 24.3
Extended Data Figure 8-1A, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for DAT-Cre-negative/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 3(M = 0, F = 3) Compartment p < 0.001, F(2,6) = 48.7Multiple comparisonsPaired vs unpaired p = 0.358; 95% CI: –15.8 to 5.46Paired vs neutral p < 0.001; 95% CI: 16.1 to 37.3Unpaired vs neutral p < 0.001; 95% CI: 21.2 to 42.5
Extended Data Figure 8-1B, leftBehavioral analysis of DAT-Cre/eYFP throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 3(M = 0, F = 3) Interaction: p = 0.677, F(12,24) = 0.767Day: p = 0.935, F(6,12) = 0.281Compartment: p = 0.004, F(2,4) = 27.9Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p < 0.001; 95% CI: –62.8 to –22.5Day3 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –64.9 to –24.6Paired vs neutral p = 0.198; 95% CI: –3.52 to 36.7Day4 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –63.5 to –23.2Paired vs neutral p = 0.222; 95% CI: –3.85 to 36.4Day5 (CR)Paired vs unpaired p < 0.001; 95% CI: –65.9 to –25.6Paired vs neutral p = 0.251; 95% CI: –4.21 to 36.1Day6 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –70.7 to –30.5Paired vs neutral p < 0.001; 95% CI: 45.8 to 86.1Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –55.5 to –15.2Paired vs neutral p < 0.001; 95% CI: 31.3 to 71.6Day8 (CR)Paired vs unpaired p < 0.001; 95% CI: –66.1 to –25.8Paired vs neutral p < 0.001; 95% CI: –42.7 to 82.9
Reversal parameters:Day3 paired vs Day6 unpaired p > 0.999; 95% CI: –17.8 to 22.5Day3 paired vs Day7 unpaired p > 0.999; 95% CI: –23.1 to 17.2Day4 paired vs Day6 unpaired p > 0.999; 95% CI: –17.4 to 22.9Day4 paired vs Day7 unpaired p > 0.999; 95% CI: –22.7 to 17.5Day5 paired vs Day8 unpaired p > 0.999; 95% CI: –20.4 to 19.9
Extended Data Figure 8-1B, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for DAT-Cre/eYFP mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 3(M = 0, F = 3) Compartment p = 0.127, F(2,6) = 2.97Multiple comparisonsPaired vs unpaired p > 0.999; 95% CI: –55.6 to 54.5Paired vs neutral p = 0.171; 95% CI: –17.5 to 92.6Unpaired vs neutral p = 0.165; 95% CI: –16.9 to 93.1
Extended Data Figure 8-1C, leftBehavioral analysis of DAT-Cre controls (pooled) throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 6(M = 0, F = 6) Interaction: p = 0.494, F(12,60) = 0.963Day: p = 0.929, F(6,30) = 0.306Compartment: p < 0.001 F(2,10) = 18.6Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p < 0.001; 95% CI: –48.6 to –20.8Day3 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –47.1 to –19.4Paired vs neutral p = 0.004; 95% CI: 3.15 to 30.9Day4 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –44.7 to –16.9Paired vs neutral p < 0.001; 95% CI: 5.52 to 33.3Day5 (CR)Paired vs unpaired p < 0.001; 95% CI: –47.6 to –19.8Paired vs neutral p = 0.003; 95% CI: 3.42 to 31.2Day6 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –42.9 to –15.1Paired vs neutral p < 0.001; 95% CI: 36.5 to 64.3Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –37.4 to –9.64Paired vs neutral p < 0.001; 95% CI: 27.8 to 55.6Day8 (CR)Paired vs unpaired p < 0.001; 95% CI: –50.1 to –22.3Paired vs neutral p < 0.001; 95% CI: 40.2 to 67.9Reversal parameters:Day3 paired vs Day6 unpaired p > 0.999; 95% CI: –16.7 to 11.1Day3 paired vs Day7 unpaired p > 0.999; 95% CI: –17.5 to 10.3Day4 paired vs Day6 unpaired p > 0.999; 95% CI: –15.1 to 12.7Day4 paired vs Day7 unpaired p > 0.999; 95% CI: –15.9 to 11.9Day5 paired vs Day8 unpaired p > 0.999; 95% CI: –13.3 to 14.5
Extended Data Figure 8-1C, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for DAT-Cre control mice (pooled) Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 6(M = 0, F = 6) Compartment p = 0.015, F(2,6) = 9.27Multiple comparisonsPaired vs unpaired p = 0.946; 95% CI: –30.6 to 24.8Paired vs neutral p = 0.028; 95% CI: 4.44 to 59.8Unpaired vs neutral p = 0.019; 95% CI: 7.30 to 62.7
Extended Data Figure 8-1E, leftBehavioral analysis of DAT-Cre/ChR2 mice tested on high power, throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 10(M = 2, F = 8) Interaction: p < 0.001, F(12,36) = 22.6Day: p = 0.455, F(6,18) = 1Compartment: p < 0.001, F(2,6) = 105Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p > 0.999; 95% CI: –45.7 to 26.7Day3 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 26.2 to 98.6Paired vs neutral p < 0.001; 95% CI: 38.5 to 111Day4 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 42.7 to 115Paired vs neutral p < 0.001; 95% CI: 47.1 to 119Day5 (CR)Paired vs unpaired p < 0.001; 95% CI: 17.4 to 89.8Paired vs neutral p < 0.001; 95% CI: 16.5 to 88.8Day6 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –98.0 to –25.6Paired vs neutral p < 0.001; 95% CI: 36.5 to 109Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –109 to –37.0Paired vs neutral p < 0.001; 95% CI: 42.3 to 115Day8 (CR)Paired vs unpaired p = 0.407; 95% CI: –62.5 to 9.72Paired vs neutral p = 0.030; 95% CI: 1.98 to 74.3
Reversal parameters:Day3 paired vs Day6 unpaired p < 0.001; 95% CI: 26.5 to 98.9Day3 paired vs Day7 unpaired p < 0.001; 95% CI: 32.1 to 104Day4 paired vs Day6 unpaired p < 0.001; 95% CI: 34.8 to 107Day4 paired vs Day7 unpaired p < 0.001; 95% CI: 40.5 to 113Day5 paired vs Day8 unpaired p < 0.001; 95% CI: 4.15 to 76.5
Extended Data Figure 8-1E, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for DAT-Cre/ChR2 mice under high power stimulation Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 4(M = 0, F = 4) Compartment p < 0.001, F(2,6) = 404Multiple comparisonsPaired vs unpaired p < 0.001; 95% CI: 59.9 to 78.2Paired vs neutral p < 0.001; 95% CI: 68.1 to 86.5Unpaired vs neutral p = 0.074; 95% CI: –0.934 to 17.4
Figure 8C, leftBehavioral analysis of Vglut2-Cre/ChR2 mice throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 7(M = 2, F = 5) Interaction: p < 0.001, F(12,72) = 16.1Day: p = 0.181, F(6,36) = 1.58Compartment: p < 0.001, F(2,12) = 40.9Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p > 0.999; 95% CI: –28.1 to 26.6Day3 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –71.9 to –17.2Paired vs neutral p > 0.999; 95% CI: –18.0 to 36.7Day4 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –68.1 to –13.4Paired vs neutral p > 0.997; 95% CI: –16.9 to 37.8Day5 (CR)Paired vs unpaired p = 0.998; 95% CI: –37.8 to 16.9Paired vs neutral p = 0.019; 95% CI: 2.42 to 57.1Day6 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 32.9 to 87.6Paired vs neutral p > 0.999; 95% CI: –28.8 to 25.9Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 27.0 to 81.7Paired vs neutral p > 0.999; 95% CI: –28.9 to 25.8Day8 (CR)Paired vs unpaired p = 0.783; 95% CI: –10.8 to 43.9Paired vs neutral p = 0.055; 95% CI: –0.268 to 54.4Reversal parameters:Day3 paired vs Day6 unpaired p < 0.001; 95% CI: –78.7 to –24.1Day3 paired vs Day7 unpaired p < 0.001; 95% CI: –74.8 to –20.1Day4 paired vs Day6 unpaired p < 0.001; 95% CI: –77.1 to –22.4Day4 paired vs Day7 unpaired p < 0.001; 95% CI: –73.2 to –18.5Day5 paired vs Day8 unpaired p = 0.952; 95% CI: –41.0 to 13.7
Figure 8C (right) time spent in paired, unpaired and neutral compartments during the 4 RT-PP days for Vglut2-Cre/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 7(M = 2, F = 5) Compartment p < 0.001, F(2,6) = 162Multiple comparisonsPaired vs unpaired p < 0.001; 95% CI: –60.2 to –39.7Paired vs neutral p = 0.469; 95% CI: –6.08 to 14.5Unpaired vs neutral p < 0.001; 95% CI: 43.9 to 64.4
Figure 8D, leftBehavioral analysis of Calb2-Cre/ChR2 mice throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 7(M = 0, F = 7) Interaction: p = 0.163, F(12,72) = 1.45Day: p = 0.567, F(6,36) = 0.813Compartment: p < 0.001, F(2,12) = 27Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.096; 95% CI: –33.3 to 1.13Day3 (RT-PP)Paired vs unpaired p = 0.343; 95% CI: –30.6 to 3.82Paired vs neutral p = 0.010; 95% CI: 2.52 to 37.0Day4 (RT-PP)Paired vs unpaired p > 0.999; 95% CI: –21.1 to 13.4Paired vs neutral p < 0.001; 95% CI: 8.22 to 42.7Day5 (CR)Paired vs unpaired p > 0.999; 95% CI: 13.4 to 47.9Paired vs neutral p < 0.001; 95% CI: –15.7 to 18.8Day6 (RT-PP)Paired vs unpaired p > 0.999; 95% CI: –18.2 to 16.2Paired vs neutral p < 0.001; 95% CI: 13.0 to 47.5Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –17.6 to 16.9Paired vs neutral p > 0.999; 95% CI: 10.8 to 45.2Day8 (CR)Paired vs unpaired p < 0.001; 95% CI: –13.1 to 21.3Paired vs neutral p > 0.999; 95% CI: 7.45 to 41.9
Reversal parameters:Day3 paired vs Day6 unpaired p = 0.991; 95% CI: –24.6 to 9.91Day3 paired vs Day7 unpaired p = 0.995; 95% CI: –24.2 to 10.2Day4 paired vs Day6 unpaired p > 0.999; 95% CI: –19.5 to 15.0Day4 paired vs Day7 unpaired p > 0.999; 95% CI: –19.1 to 15.3Day5 paired vs Day8 unpaired p > 0.999; 95% CI: –17.2 to 17.3
Figure 8D, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for Calb2-Cre/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 7(M = 0, F = 7) Compartmentp < 0.001, F(2,6) = 90.1Multiple comparisonsPaired vs unpaired p = 0.297; 95% CI: –11.4 to 3.42Paired vs neutral p < 0.001; 95% CI: 18.5 to 33.3Unpaired vs neutral p < 0.001; 95% CI: 22.4 to 37.3
Extended Data Figure 8-1FBehavioral analysis of Calb2-Cre/ChR2 mice tested on high power, throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 7(M = 0, F = 7) Interaction: p = 0.927, F(12,72) = 0.469Day: p = 0.661, F(6,36) = 0.688Compartment: p = 0.001, F(2,12) = 12.5Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.104; 95% CI: –33.5 to 1.28Day3 (RT-PP)Paired vs unpaired p = 0.995; 95% CI: –24.4 to 10.4Paired vs neutral p = 0.019; 95% CI: 1.56 to 36.3Day4 (RT-PP)Paired vs unpaired p > 0.999; 95% CI: –22.6 to 12.2Paired vs neutral p < 0.001; 95% CI: 47.1 to 119Day5 (CR)Paired vs unpaired p = 0.742; 95% CI: –28.2 to 6.54Paired vs neutral p = 0.015; 95% CI: 1.87 to 36.6Day6 (RT-PP)Paired vs unpaired p = 0.937; 95% CI: –26.3 to 8.46Paired vs neutral p < 0.001; 95% CI: 11.1 to 45.9Day7 (RT-PP)Paired vs unpaired p > 0.999; 95% CI: –22.3 to 12.5Paired vs neutral p < 0.001; 95% CI: 7.32 to 42.1Day8 (CR)Paired vs unpaired p = 0.976; 95% CI: –25.5 to 9.30Paired vs neutral p < 0.001; 95% CI: 7.52 to 42.3Reversal parameters:Day3 paired vs Day6 unpaired p > 0.999; 95% CI: –17.0 to 17.8Day3 paired vs Day7 unpaired p > 0.999; 95% CI: –18.4 to 16.4Day4 paired vs Day6 unpaired p > 0.999; 95% CI: –15.1 to 19.6Day4 paired vs Day7 unpaired p > 0.999; 95% CI: –16.5 to 18.2Day5 paired vs Day8 unpaired p > 0.999; 95% CI: –17.5 to 17.3
Extended Data Figure 8-1F, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for Calb2-Cre/ChR2 mice under high power stimulation Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 7(M = 0, F = 7) Compartment p < 0.001, F(2,6) = 47.3Multiple comparisonsPaired vs unpaired p = 0.988; 95% CI: –8.15 to 8.97Paired vs neutral p < 0.001; 95% CI: 15.1 to 32.3Unpaired vs neutral p < 0.001; 95% CI: 14.7 to 31.8
Figure 8E, leftBehavioral analysis of NEX-Cre/ChR2 mice throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 5(M = 1, F = 4) Interaction: p < 0.001, F(12,48) = 4.63Day: p = 0.307, F(6,24) = 1.27Compartment: p < 0.001, F(2,8) = 76.8Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p > 0.999; 95% CI: –18.7 to 24.9Day3 (RT-PP)Paired vs unpaired p = 0.414; 95% CI: –5.70 to 37.9Paired vs neutral p < 0.001; 95% CI: 17.1 to 60.7Day4 (RT-PP)Paired vs unpaired p > 0.999; 95% CI: –17.5 to 26.1Paired vs neutral p < 0.001; 95% CI: 16.6 to 60.3Day5 (CR)Paired vs unpaired p > 0.999; 95% CI: 12.0 to 55.6Paired vs neutral p < 0.001; 95% CI: –5.03 to 38.6Day6 (RT-PP)Paired vs unpaired p = 0.020; 95% CI: –45.5 to –1.92Paired vs neutral p < 0.001; 95% CI: 15.1 to 58.7Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –51.8 to –8.16Paired vs neutral p < 0.001; 95% CI: 20.5 to 64.1Day8 (CR)Paired vs unpaired p = 0.937; 95% CI: –32.7 to 10.9Paired vs neutral p < 0.001; 95% CI: 16.3 to 59.9
Reversal parameters:Day3 paired vs Day6 unpaired p = 0.049; 95% CI: 0.0239 to 43.6Day3 paired vs Day7 unpaired p = 0.016; 95% CI: 2.38 to 46.0Day4 paired vs Day6 unpaired p = 0.252; 95% CI: –4.06 to 39.5Day4 paired vs Day7 unpaired p = 0.105; 95% CI: –1.71 to 41.9Day5 paired vs Day8 unpaired p = 0.998; 95% CI: –14.0 to 29.6
Figure 8E, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for NEX-Cre/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 5(M = 1, F = 4) Compartment p < 0.001, F(2,6) = 39.7Multiple comparisonsPaired vs unpaired p = 0.013; 95% CI: 5.03 to 32.0Paired vs neutral p < 0.001; 95% CI: 25.7 to 52.6Unpaired vs neutral p = 0.008; 95% CI: 7.16 to 34.1
Extended Data Figure 8-1G, leftBehavioral analysis of NEX-Cre/ChR2 mice tested on high power, throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 4(M = 1, F = 3) Interaction: p < 0.001, F(12,36) = 8.58Day: p = 0.252, F(6,18) = 1.44Compartment: p < 0.001, F(2,6) = 48.3Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.369; 95% CI: –25.0 to 3.62Day3 (RT-PP)Paired vs unpaired p = 0.358; 95% CI: –3.54 to 25.1Paired vs neutral p < 0.001; 95% CI: 16.0 to 44.6Day4 (RT-PP)Paired vs unpaired p = 0.003; 95% CI: 3.97 to 32.6Paired vs neutral p < 0.001; 95% CI: 24.9 to 53.5Day5 (CR)Paired vs unpaired p = 0.084; 95% CI: –0.819 to 27.8Paired vs neutral p < 0.001; 95% CI: 19.7 to 48.3Day6 (RT-PP)Paired vs unpaired p = 0.087; 95% CI: –27.8 to 0.877Paired vs neutral p < 0.001; 95% CI: 17.7 to 46.4Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –34.7 to –6.03Paired vs neutral p < 0.001; 95% CI: 21.8 to 50.5Day8 (CR)Paired vs unpaired p = 0.798; 95% CI: –22.5 to 6.11Paired vs neutral p < 0.001; 95% CI: 13.7 to 42.3Reversal parameters:Day3 paired vs Day6 unpaired p = 0.203; 95% CI: –2.36 to 26.3Day3 paired vs Day7 unpaired p = 0.028; 95% CI: 0.881 to 29.5Day4 paired vs Day6 unpaired p = 0.005; 95% CI: 3.12 to 31.8Day4 paired vs Day7 unpaired p < 0.001; 95% CI: 6.36 to 35.0Day5 paired vs Day8 unpaired p = 0.202; 95% CI: –2.35 to 26.3
Extended Data Figure 8-1G, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for NEX-Cre/ChR2 mice under high-power stimulation Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 4(M = 1, F = 3) Compartment p < 0.001, F(2,6) = 178Multiple comparisonsPaired vs unpaired p < 0.001; 95% CI: 10.1 to 21.3Paired vs neutral p < 0.001; 95% CI: 28.8 to 40.0Unpaired vs neutral p < 0.001; 95% CI: 13.1 to 24.3
Extended Data Figure 8-1H, leftBehavioral analysis of bilaterally injected NEX-Cre/ChR2 mice throughout the opto-behavioral experiments Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 4(M = 0, F = 4) Interaction: p = 0.040, F(12,36) = 2.13Day: p = 0.384, F(6,18) = 1.13Compartment: p < 0.001, F(2,6) = 43.3Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.999; 95% CI: –50.7 to 25.1Day3 (RT-PP)Paired vs unpaired p = 0.998; 95% CI: –24.6 to 51.2Paired vs neutral p = 0.017; 95% CI: 4.27 to 80.1Day4 (RT-PP)Paired vs unpaired p = 0.768; 95% CI: –15.7 to 60.2Paired vs neutral p = 0.003; 95% CI: 10.3 to 86.1Day5 (CR)Paired vs unpaired p = 0.974; 95% CI: –21.2 to 54.7Paired vs neutral p = 0.015; 95% CI: 4.63 to 80.5Day6 (RT-PP)Paired vs unpaired p > 0.999; 95% CI: –49.6 to 26.3Paired vs neutral p = 0.029; 95% CI: 2.13 to 78.0Day7 (RT-PP)Paired vs unpaired p = 0.999; 95% CI: –52.5 to 23.3Paired vs neutral p = 0.019; 95% CI: 3.69 to 79.5Day8 (CR)Paired vs unpaired p = 0.185; 95% CI: –70.1 to 5.78Paired vs neutral p < 0.001; 95% CI: 14.2 to 90.0
Reversal parameters:Day3 paired vs Day6 unpaired p = 0.999; 95% CI: –25.0 to 50.8Day3 paired vs Day7 unpaired p = 0.995; 95% CI: –23.6 to 52.3Day4 paired vs Day6 unpaired p = 0.952; 95% CI: –20.0 to 55.8Day4 paired vs Day7 unpaired p = 0.999; 95% CI: –18.6 to 57.3Day5 paired vs Day8 unpaired p = 0.668; 95% CI: –14.1 to 61.8
Extended Data Figure 8-1H, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for bilaterally injected NEX-Cre/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 4(M = 0, F = 4) Compartment p < 0.001, F(2,6) = 331Multiple comparisonsPaired vs unpaired p < 0.001; 95% CI: 10.1 to 20.8Paired vs neutral p < 0.001; 95% CI: 37.7 to 48.4Unpaired vs neutral p < 0.001; 95% CI: 22.2 to 32.9
Figure 8F, left Behavioral analysis of bilaterally injected NEX-Cre/ChR2 mice throughout the opto-behavioral experiments, tested on high power Normally distributed Two-way RM ANOVA followed by Tukey’s multiple comparison test N = 4(M = 0, F = 4) Interaction: p < 0.001, F(12,36) = 9.03Day: p = 0.310, F(6,18) = 1.29Compartment: p < 0.001, F(2,6) = 36.5Multiple comparisons (of interest)Day2 (pre-test)Paired vs unpaired p = 0.982; 95% CI: –42.9 to 17.4Day3 (RT-PP)Paired vs unpaired p = 0.349; 95% CI: –7.34 to 53.0Paired vs neutral p < 0.001; 95% CI: 20.0 to 80.3Day4 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: 14.1 to 74.4Paired vs neutral p < 0.001; 95% CI: 30.8 to 91.1Day5 (CR)Paired vs unpaired p > 0.999; 95% CI: –29.7 to 30.6Paired vs neutral p = 0.002; 95% CI: 9.24 to 69.5Day6 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –76.1 to –15.8Paired vs neutral p < 0.001; 95% CI: 28.5 to 88.8Day7 (RT-PP)Paired vs unpaired p < 0.001; 95% CI: –74.4 to –14.1Paired vs neutral p < 0.001; 95% CI: 27.0 to 87.3Day8 (CR)Paired vs unpaired p = 0.989; 95% CI: –42.4 to 17.9Paired vs neutral p = 0.006; 95% CI: 6.19 to 66.5Reversal parameters:Day3 paired vs Day6 unpaired p = 0.009; 95% CI: 5.24 to 65.5Day3 paired vs Day7 unpaired p = 0.011; 95% CI: 4.65 to 64.9Day4 paired vs Day6 unpaired p < 0.001; 95% CI: 16.0 to 76.3Day4 paired vs Day7 unpaired p < 0.001; 95% CI: 15.4 to 75.7Day5 paired vs Day8 unpaired p > 0.999; 95% CI: –20.8 to 39.5
Figure 8F, rightTime spent in paired, unpaired, and neutral compartments during the four RT-PP days for NEX-Cre/ChR2 mice bilaterally injected and under high-power stimulation Assumed normality RM one-way ANOVA followed by Tukey’s multiple comparison test N = 4(M = 0, F = 4) Compartment p < 0.001, F(2,6) = 106Multiple comparisonsPaired vs unpaired p < 0.001; 95% CI: 27.1 to 51.6Paired vs neutral p < 0.001; 95% CI: 44.5 to 69.0Unpaired vs neutral p = 0.011; 95% CI: 5.19 to 29.7
Extended Data Figure 8-1IiiBehavioral analysis of Vglut2-Cre throughout the NCP experiments Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 5(M = 0, F = 5) Interaction: p = 0.002, F(4,16) = 6.90Day: p = 0.410, F(2,8) = 1Compartment: p < 0.001, F(2,8) = 70.9Multiple comparisons (of interest)Stimulation 1Neutral vs Paired1 p = 0.009; 95% CI: –93.5 to –10.6Neutral vs Paired2 p = 0.004; 95% CI: –98.6 to –15.7Paired 1 vs Paired2 p > 0.999; 95% CI: –36.4 to 46.5Stimulation 2Neutral vs Paired1 p < 0.001; 95% CI: –113 to –29.9Neutral vs Paired2 p < 0.001; 95% CI: –112 to –29Paired 1 vs Paired2 p > 0.999; 95% CI: –42.3 to 40.6CRNeutral vs Paired1 p = 0.998; 95% CI: –49.8 to 33.1Neutral vs Paired2 p > 0.999; 95% CI: –35.5 to 47.4Paired 1 vs Paired2 p = 0.938; 95% CI: –55.7 to 27.2
Extended Data Figure 8-1IiiiTime spent in paired1, paired2, and neutral compartments during the two NCP days for Vglut2-Cre/ChR2 mice Normally distributed RM one-way ANOVA followed by Tukey’s multiple comparison test N = 5(M = 0, F = 5) Compartment p = 0.018, F(2,2) = 54.2Multiple comparisonsPaired1 vs Paired2 p = 0.951; 95% CI: –38.9 to 43.2Paired1 vs Neutral p = 0.023; 95% CI: –103 to –20.7Paired2 vs Neutral p = 0.021; 95% CI: –105 to –22.8